Cvs (CVS) Holder Johnson Investment Counsel Has Lowered Its Holding by $418,527; Johnson & Johnson (JNJ) Holder Crossvault Capital Management Has Lifted Stake by $971,360

January 19, 2018 - By Darrin Black

Crossvault Capital Management Llc increased its stake in Johnson & Johnson (JNJ) by 18.16% based on its latest 2017Q3 regulatory filing with the SEC. Crossvault Capital Management Llc bought 7,472 shares as the company’s stock rose 6.85% with the market. The institutional investor held 48,618 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $6.32 million, up from 41,146 at the end of the previous reported quarter. Crossvault Capital Management Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $394.23B market cap company. The stock decreased 0.12% or $0.1748 during the last trading session, reaching $146.7452. About 3.53M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 19, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Johnson Investment Counsel Inc decreased its stake in Cvs Corporation (CVS) by 0.99% based on its latest 2017Q3 regulatory filing with the SEC. Johnson Investment Counsel Inc sold 5,167 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 518,806 shares of the medical and nursing services company at the end of 2017Q3, valued at $42.19M, down from 523,973 at the end of the previous reported quarter. Johnson Investment Counsel Inc who had been investing in Cvs Corporation for a number of months, seems to be less bullish one the $80.79 billion market cap company. The stock increased 0.50% or $0.3949 during the last trading session, reaching $79.7449. About 5.14M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 19, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It has no change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Univest Of Pennsylvania invested in 87,369 shares. Acropolis Investment Management Limited Com holds 0.52% or 19,303 shares in its portfolio. Linscomb & Williams holds 0.7% or 62,922 shares in its portfolio. Assetmark Inc holds 0.33% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 225,411 shares. Davis holds 0.37% or 4,790 shares in its portfolio. Envestnet Asset Management Inc invested in 618,266 shares or 0.19% of the stock. Founders Ltd Liability Co has invested 3.46% in Johnson & Johnson (NYSE:JNJ). 10 owns 3.56% invested in Johnson & Johnson (NYSE:JNJ) for 108,284 shares. 408 were accumulated by James. Weatherstone Cap Mngmt invested in 0.2% or 2,305 shares. Confluence Management Limited Liability reported 1.02M shares. Highland Management Ltd Limited Liability Company stated it has 1.94% in Johnson & Johnson (NYSE:JNJ). Acg Wealth owns 50,076 shares for 1.13% of their portfolio. Gould Asset Mngmt Ltd Llc Ca reported 0.13% stake. Cortland Assocs Mo holds 0.08% or 3,414 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 86 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Monday, July 10 by BMO Capital Markets. The rating was downgraded by BTIG Research on Friday, July 21 to “Sell”. The rating was maintained by Wells Fargo on Wednesday, October 18 with “Buy”. Jefferies maintained it with “Hold” rating and $109 target in Tuesday, June 14 report. The stock of Johnson & Johnson (NYSE:JNJ) has “Hold” rating given on Tuesday, September 13 by Jefferies. Argus Research upgraded Johnson & Johnson (NYSE:JNJ) rating on Wednesday, July 20. Argus Research has “Buy” rating and $145 target. The rating was maintained by UBS on Thursday, August 31 with “Buy”. The rating was maintained by S&P Research on Wednesday, October 14 with “Buy”. The firm has “Overweight” rating given on Monday, May 15 by JP Morgan. The company was downgraded on Friday, July 21 by Atlantic Securities.

Crossvault Capital Management Llc, which manages about $184.05 million and $174.24 million US Long portfolio, decreased its stake in Ibm Corp (NYSE:IBM) by 22,515 shares to 8,045 shares, valued at $1.17M in 2017Q3, according to the filing.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 66 analyst reports since July 22, 2015 according to SRatingsIntel. As per Thursday, May 12, the company rating was maintained by Jefferies. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Evercore on Wednesday, August 19. The firm has “Buy” rating given on Monday, August 24 by Vetr. The stock has “Hold” rating by Robert W. Baird on Wednesday, January 17. Jefferies maintained CVS Health Corporation (NYSE:CVS) on Tuesday, November 7 with “Hold” rating. Wolfe Research downgraded the stock to “Peer Perform” rating in Monday, August 14 report. The firm has “Hold” rating given on Thursday, January 4 by Robert W. Baird. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Wednesday, August 16. The stock has “Overweight” rating by Barclays Capital on Friday, December 18. Robert W. Baird maintained the shares of CVS in report on Friday, October 27 with “Hold” rating.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It fall, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Oppenheimer has 58,660 shares. Moreover, Tiedemann Wealth Mgmt Ltd has 0.09% invested in CVS Health Corporation (NYSE:CVS) for 33,503 shares. Cim Invest Mangement holds 0.44% of its portfolio in CVS Health Corporation (NYSE:CVS) for 15,034 shares. Chase Inv Counsel Corp holds 0.15% of its portfolio in CVS Health Corporation (NYSE:CVS) for 3,470 shares. Atria Invests Limited Liability reported 38,883 shares. Boston Family Office Ltd Limited Liability Company has 1.04% invested in CVS Health Corporation (NYSE:CVS) for 112,163 shares. Diversified Communication holds 2,687 shares or 0.02% of its portfolio. Smithbridge Asset Mngmt De reported 0.91% of its portfolio in CVS Health Corporation (NYSE:CVS). Atalanta Sosnoff Capital Limited Liability Co reported 6,570 shares. Private Advisor Grp Lc stated it has 0.08% of its portfolio in CVS Health Corporation (NYSE:CVS). Retirement System Of Alabama, a Alabama-based fund reported 695,490 shares. State Common Retirement Fund has 0.34% invested in CVS Health Corporation (NYSE:CVS). Excalibur Corp holds 0.96% or 13,866 shares. 127,607 are owned by Raymond James Trust Na. Wilbanks Smith & Thomas Asset Mgmt Ltd Company holds 26,939 shares or 0.18% of its portfolio.

Since August 16, 2017, it had 0 insider buys, and 7 insider sales for $58.32 million activity. Moriarty Thomas M sold $7.19M worth of CVS Health Corporation (NYSE:CVS) on Monday, September 11. $20.03 million worth of CVS Health Corporation (NYSE:CVS) was sold by MERLO LARRY J on Wednesday, August 23. Foulkes Helena also sold $3.22M worth of CVS Health Corporation (NYSE:CVS) on Friday, September 15. 2,500 shares were sold by SWIFT RICHARD J, worth $199,050 on Wednesday, August 16. Denton David M sold $18.88M worth of CVS Health Corporation (NYSE:CVS) on Monday, September 11.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com